amlashbispecificsbloodcancerscarechicagoclinicalcllcmlcontroversiescostdahiyadatadiscussdiscussesdiseasedlbcldrseditorendpointsevolutionfellowsfollicularfrontlinefuturehighhighlightshodgkininnovationsinsidelatestlivelymphomamalignanciesmanagementmbbsmdmdsmmmphmpnmrdmyelomanewsnextnhlquestionquestionsrevolutionrisksaysshadmansohospecialspiegeltellstherapiestherapytimetreatingtreatmenttrialsunansweredupdatesususmanivenugopalworld